Flecainide acetate and Taste - impaired - a phase IV clinical study of FDA data

Summary:

Taste - impaired is reported as a side effect among people who take Flecainide acetate (flecainide acetate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin D3, and have Osteoporosis.

The phase IV clinical study analyzes which people have Taste - impaired when taking Flecainide acetate. It is created by eHealthMe based on reports of 6,177 people who have side effects when taking Flecainide acetate from the FDA, and is updated regularly.

What is Flecainide acetate?

Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 7,176 Flecainide acetate users. Check the latest studies of Flecainide acetate.

What is Taste - impaired?

Taste - impaired is found to be associated with 1,832 drugs and 3,110 conditions by eHealthMe. Check the latest studies of Taste - impaired.

On Jul, 13, 2026

6,177 people reported to have side effects when taking Flecainide acetate.
Among them, 33 people (0.53%) have Taste - impaired.

Could Flecainide acetate cause Taste - impaired?

Among these 33 people:

How long have people been on Flecainide acetate when they have Taste - impaired? *

What is the gender of people who have Taste - impaired when taking Flecainide acetate? *

female: 56.25 %
male: 43.75 %

What is the age of people who have Taste - impaired when taking Flecainide acetate? *

What are other drugs people take besides Flecainide acetate? *

What are other side effects people have besides Taste - impaired? *

Diarrhea: 8 people, 24.24%
Nausea (feeling of having an urge to vomit): 8 people, 24.24%
Fatigue (feeling of tiredness): 8 people, 24.24%
Headache (pain in head): 7 people, 21.21%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 18.18%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 18.18%
Weakness: 5 people, 15.15%
High Blood Pressure: 5 people, 15.15%
Heart Rate Irregular: 5 people, 15.15%
Constipation: 5 people, 15.15%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 9.09%
Osteoporosis (bones weak and more likely to break): 3 people, 9.09%
Cardiomyopathy (weakening of the heart muscle): 2 people, 6.06%
Multiple Myeloma (cancer of the plasma cells): 2 people, 6.06%
Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 6.06%
Insomnia (sleeplessness): 2 people, 6.06%
Endometrial Cancer: 2 people, 6.06%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 1 person, 3.03%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.03%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Flecainide acetate and have Taste - impaired?

- Check whether Taste - impaired is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flecainide acetate:

Flecainide acetate (7,176 reports)

Taste - impaired treatments and more:

Taste - impaired (83,126 reports)

Browse all side effects of Flecainide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Taste - impaired:

Taste - impaired (1,832 drugs)

Browse all the conditions that are associated with Taste - impaired:

Taste - impaired (3,110 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on flecainide acetate (the active ingredients of Flecainide acetate) and Flecainide acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.